TARDOC: Health Insurers Announce Reimbursement Claims – Specialists Under Scrutiny
Initial billing data suggests some specialist areas benefit more than intended. Meanwhile, the intended strengthening of general practice medicine has not yet occurred. Insurers are therefore examining tariff effects and unusual billing patterns.
TARDOC Aimed to Curb Specialists and Strengthen General Practitioners
TARDOC is part of the new overall tariff system for outpatient medical services. Since the beginning of 2026, these services have been billed either via TARDOC or through outpatient flat rates. The new system replaces TARMED, which was in effect since 2004.
A key goal of the reform was to align tariff structures more closely with actual medical services and to correct perverse incentives of the old system. Simultaneously, primary care was to be strengthened.
This addresses a healthcare policy problem: specialist medicine can generate higher reimbursements, while general practitioners play a central role in primary care and there is simultaneously a shortage of them.
The first few months with TARDOC now show that the desired shift is not occurring automatically.
Individual Specialist Areas Show Stronger Growth Than Expected
According to initial billing data from insurers, reimbursements in several specialized fields exceed the level prior to TARDOC's introduction. SRF names among others Dermatology, Ophthalmology, Urology, and Surgery.
Saskia Schenker, director of the health insurance association prio.swiss, speaks of areas that are «overshooting». Particularly in ophthalmology and – less visibly – in dermatology, a stronger development than expected is observed.
However, the exact reasons for this are not yet definitively clarified. According to insurers, several explanations are possible: individual tariff positions might be too generously valued, the number of services provided might have increased, or impermissible billing patterns might exist.
General Practice Medicine Not Benefiting as Planned So Far
At the same time, the desired improvement in general practice medicine is not materializing. The Swiss Association of General Practitioners and Pediatricians criticizes that primary care has not been sufficiently strengthened by TARDOC.
The association speaks of a significant cost increase in the outpatient sector, while the expected strengthening of general practice medicine has failed to occur. In some cantons, even a devaluation has been observed. Only pediatricians and general practitioners show moderate improvement.
For general practitioners, this is politically sensitive: if the new tariff system does not reduce the differences between primary care and specialist medicine, a major goal of the reform could be missed.
Insurers See Several Possible Causes
It is not yet clear whether the development is actually due to an error in the tariff. This distinction is crucial.
One possibility is that individual services within TARDOC were overvalued. According to prio.swiss, certain specialist areas might have outdated data as a basis, for instance. If medical procedures and the time required for them have changed, the stored time values might be too high.
A second possibility would be an expansion of volume: if more services are provided or billed more frequently than before, total costs can increase without necessarily meaning an individual tariff position is incorrectly valued.
As a third possibility, insurers are investigating billing patterns that might violate tariff rules.
Treatments Over Two Days Instead of One
Saskia Schenker gives an example in connection with certain flat rates. These are designed so that a treatment should generally occur within one day. In some cases, however, patients are scheduled for two different days, allowing the respective flat rate to be charged twice.
Schenker describes this practice as impermissible. Insurers intend to identify such patterns using billing data and verify them as part of their economic efficiency controls.
The distinction here is important: these are currently observations or suspicions identified by insurers. This does not imply that a particular specialty or the medical profession as a whole is systematically billing incorrectly.
Schenker herself emphasizes that the vast majority of doctors work correctly.
Reimbursement Claims to Follow
Health insurers will first fully evaluate the billing data from the initial months. If impermissible billings are confirmed, the corresponding amounts will be reclaimed.
Schenker explicitly uses the term «fraud prevention» in this context. However, the term does not mean that it has already been established that the investigated doctors have committed fraud. First, individual cases must be examined and the respective billings assessed.
This is precisely why the actual scale of the problem is also unknown. Neither the number of affected practices nor the amount of potential reimbursements can currently be reliably quantified.
The Tariff Itself Also Under Scrutiny
The discussion will therefore not solely revolve around possible misconduct by individual service providers. The design of TARDOC itself might also need adjustment.
The new tariff system is explicitly designed as a learning system. Corrections are possible and should be made based on experience with practical application. According to prio.swiss, a revision for 2027 has already been submitted.
At the same time, requirements for cost neutrality apply. The Federal Council demands that the introduction of the new tariff system does not lead to unjustified additional costs solely due to the new tariff structure. For the period after its introduction, there is therefore a growth corridor and correction mechanisms if cost development exceeds the specified framework.
Data Not Yet Conclusive
Despite the sensitivity of the initial figures, there is an important caveat: the data situation is still in its early stages.
The FMH stated on September 3, 2026, that it currently lacks sufficiently robust data to reliably assess the effects of TARDOC on individual specialties. At the same time, the doctors' association supports the goal of strengthening general practice and pediatric medicine.
Thus, two statements currently stand in contrast: insurers are already identifying clear anomalies in their initial evaluations, while the medical profession warns against hasty conclusions.
Both positions can be true simultaneously. Initial data can indicate a problem without yet proving why this problem arose or how significant it actually is.
What TARDOC Has Not Yet Achieved
After the first few months, one main conclusion can be drawn: the intended shift towards primary care is not yet clearly visible.
Simultaneously, individual specialist areas are developing more strongly than expected. Further evaluation must show whether this is due to incorrect tariff valuation, volume expansion, specific practice structures, or impermissible billing.
This is crucial for the further development of the tariff. Because a linear devaluation of all specialties would be as inappropriate as clinging to tariff positions that permanently overcompensate for individual services.
The Coming Months Will Be Decisive
Health insurers plan to continue evaluating billing data and will issue reimbursement claims for confirmed violations. At the same time, the tariff partners must clarify whether individual TARDOC positions need adjustment.
For general practice medicine, the question is whether the promised strengthening can actually be achieved. Conversely, for specialist areas, the question arises whether certain reimbursements are appropriate or need correction.
Therefore, it is not yet proven that TARDOC as a whole has failed. However, initial data shows that the redistribution of reimbursements sought by the reform has not occurred automatically.
What the complete billing data reveals will now be crucial – and whether the anomalies can be explained by tariff adjustments, changes in service provision, or indeed impermissible billing.
Sources
- SRF, September 5, 2026: «New outpatient tariff system – Unnecessary practice visits so that the specialist earns more».
- SRF, September 3, 2026: «Tardoc: General Practitioners' Association sees primary care disadvantaged».
- FMH, September 3, 2026: «Maintain outpatient medical tariff revision based on reliable data».
- Federal Office of Public Health: Information on outpatient medical tariffs and TARDOC.
